Sensorimotor gating, working and social memory deficits in mice with reduced expression of the vesicular glutamate transporter VGLUT1

Behavioural Brain Research

Volumn 228, Issue 2, 2012, Pages 328-332

  Inta, Dragos ^a   Vogt, Miriam A ^a   Perreau Lenz, Stephanie ^a   Schneider, Miriam ^a   Pfeiffer, Natascha ^a   Wojcik, Sonja M ^b   Spanagel, Rainer ^a   Gass, Peter ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Glutamate; Mice; Schizophrenia; Vesicular transporter; VGLUT1

Indexed keywords

VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MOUSE; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PREPULSE INHIBITION; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SCHIZOPHRENIA; SENSORY GATING; SOCIAL MEMORY; SPATIAL MEMORY; STARTLE REFLEX; WORKING MEMORY;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SENSORY GATING; SOCIAL BEHAVIOR; STARTLE REACTION; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 84856222601     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.12.012     Document Type: Article

References (39)

1. Amilhon B., Lepicard E., Renoir T., Mongeau R., Popa D., Poirel O., et al. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci 2010, 30:2198-2210.
2. Arguello P.A., Gogos J.A. Cognition in mouse models of schizophrenia susceptibility genes. Schizophr Bull 2010, 36:289-300.
3. Balschun D., Moechars D., Callaerts-Vegh Z., Vermaercke B., Van Acker N., Andries L., et al. Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex 2010, 20:684-693.
4. Barch D.M., Carter C.S., Hachten P.C., Usher M., Cohen J.D. The "benefits" of distractibility: mechanisms underlying increased Stroop effects in schizophrenia. Schizophr Bull 1999, 25:749-762.
5. Bitanihirwe B.K., Lim M.P., Kelley J.F., Kaneko T., Woo T.U. Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry 2009, 9:71.
6. Bolino F., Manna V., Di Cicco L., Di Michele V., Daneluzzo E., Rossi A., et al. Startle reflex habituation in functional psychoses: a controlled study. Neurosci Lett 1992, 145:126-128.
7. Boulland J.L., Qureshi T., Seal R.P., Rafiki A., Gundersen V., Bergersen L.H., et al. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol 2004, 480:264-280.
8. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 1990, 47:181.
9. Caine S.B., Geyer M.A., Swerdlow N.R. Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacol Biochem Behav 1992, 43:1201-1208.
10. Eastwood S.L., Harrison P.J. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 2005, 73:159-172.
11. Eastwood S.L., Harrison P.J. Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry 2010, 67:1010-1016.
12. Feifel D., Mexal S., Melendez G., Liu P.Y., Goldenberg J.R., Shilling P.D. The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog. Neuropsychopharmacology 2009, 34:2011-2018.
13. Fremeau R.T., Troyer M.D., Pahner I., Nygaard G.O., Tran C.H., Reimer R.J., et al. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 2001, 31:247-260.
14. Fremeau R.T., Kam K., Qureshi T., Johnson J., Copenhagen D.R., Storm-Mathisen J., et al. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 2004, 304:1815-1819.
15. Fremeau R.T., Voglmaier S., Seal R.P., Edwards R.H. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 2004, 27:98-103.
16. Garcia-Garcia A.L., Elizalde N., Matrov D., Harro J., Wojcik S.M., Venzala E., et al. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 2009, 66:275-282.
17. Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., et al. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 2002, 22:5442-5451.
18. Gras C., Amilhon B., Lepicard E.M., Poirel O., Vinatier J., Herbin M., et al. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci 2008, 11:292-300.
19. Harrison P.J., Law A.J., Eastwood S.L. Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann N Y Acad Sci 2003, 1003:94-101.
20. Heldt S.A., Green A., Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 2004, 29:1610-1619.
21. Herzog E., Gilchrist J., Gras C., Muzerelle A., Ravassard P., Giros B., et al. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience 2004, 123:983-1002.
22. Inta D., Monyer H., Sprengel R., Meyer-Lindenberg A., Gass P. Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review. Neurosci Biobehav Rev 2010, 34:285-294.
23. Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S., Varoqueaux F., et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci USA 2008, 105:1710-1715.
24. Koch M. The neurobiology of startle. Prog Neurobiol 1999, 59:107-128.
25. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
26. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995, 13:9-19.
27. Lewis D.A., Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 2006, 63:1372-1376.
28. Minelli A., Edwards R.H., Manzoni T., Conti F. Postnatal development of the vesicular transporter VGLUT1 in rat cerebral cortex. Brain Res Dev Brain Res 2003, 140:309-314.
29. Moechars D., Weston M.C., Leo S., Callaerts-Vegh Z., Goris I., Daneels G., et al. Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 2006, 26:12055-12066.
30. Ongur D., Jensen J.E., Prescot A.P., Stork C., Lundy M., Cohen B.M., et al. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry 2008, 64:718-726.
31. Oni-Orisan A., Kristiansen L.V., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol Psychiatry 2008, 63:766-775.
32. Parwani A., Duncan E.J., Bartlett E., Madonick S.H., Efferen T.R., Rajan R., et al. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 2000, 47:662-669.
33. Takamori S. VGLUTs: "exciting" times for glutamatergic research. Neurosci Res 2006, 55:343-351.
34. Terranova J.P., Chabot C., Barnouin M.C., Perrault G., Depoortere R., Griebel G., et al. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berl) 2005, 181:134-144.
35. Tordera R.M., Totterdell S., Wojcik S.M., Brose N., Elizalde N., Lasheras B., et al. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci 2007, 25:281-290.
36. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 2002, 42:165-179.
37. van den Buuse M. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 2010, 36:246-270.
38. Wojcik S.M., Rhee J.S., Herzog E., Sigler A., Jahn R., Takamori S., et al. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 2004, 101:7158-7163.
39. Wallen-Mackenzie A., Nordenankar K., Fejgin K., Lagerstrom M.C., Emilsson L., Fredriksson R., et al. Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function. J Neurosci 2009, 29:2238-2251.